Template:Percutaneous Coronary Intervention: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(19 intermediate revisions by 4 users not shown)
Line 3: Line 3:
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


'''Percutaneous Coronary Intervention Microchapters
'''Percutaneous Coronary Intervention Guidelines Microchapters
'''
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
Line 10: Line 10:
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines|Home]]
[[Percutaneous coronary intervention: basic principles and guidelines|Home]]
|-  
|-  
!
!
Line 20: Line 20:
!
!


|- bgcolor="Pink"
!
[[Percutaneous coronary intervention overview|Overview]]
|-
!
|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
!
!
Guideline Recommendations
PCI Approaches:
|-  
|-
!
!
 
|- bgcolor="CadetBlue"
|- bgcolor="PaleTurquoise"
!
!
CAD Revascularization:
CAD Revascularization:
Line 34: Line 38:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) heart team approach to revascularization decisions|Heart Team Approach to Revascularization Decisions]]
::[[Percutaneous coronary intervention heart team approach to revascularization decisions|Heart Team Approach to Revascularization Decisions]]
|-  
|-  
!
!
Line 40: Line 44:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) left main coronary artery disease|Left Main Coronary Artery Disease]]
::[[Percutaneous coronary intervention left main coronary artery disease|Left Main Coronary Artery Disease]]
|-  
|-  
!
!
Line 46: Line 50:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) non-left main coronary artery disease|Non-Left Main Coronary Artery Disease]]
:::[[Intervention in left main coronary artery disease]]
|-  
|-  
!
!
Line 52: Line 56:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) revascularization to improve symptoms|Revascularization to Improve Symptoms]]
::[[Percutaneous coronary intervention non-left main coronary artery disease|Non-Left Main Coronary Artery Disease]]
|-  
|-  
!
!
Line 58: Line 62:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) dual antiplatelet therapy compliance and stent thrombosis|Dual Antiplatelet Therapy Compliance and Stent Thrombosis]]
::[[Percutaneous coronary intervention revascularization to improve symptoms|Revascularization to Improve Symptoms]]
|-  
|-  
!
!
Line 64: Line 68:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) hybrid coronary revascularization|Hybrid Coronary Revascularization]]
::[[Percutaneous coronary intervention dual antiplatelet therapy compliance and stent thrombosis|Dual Antiplatelet Therapy Compliance and Stent Thrombosis]]
|-  
|-  
!
!
Line 70: Line 74:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Pre-procedural Considerations:
::[[Percutaneous coronary intervention hybrid coronary revascularization|Hybrid Coronary Revascularization]]
|-
|-  
!
!


|- bgcolor="PaleTurquoise"
|- bgcolor="CadetBlue"
!
!
::[[Percutaneous Coronary Intervention (PCI) radiation safety|Radiation Safety]]
Pre-procedural Considerations:
|-  
|-
!
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) contrast-induced acute kidney injury|Contrast-Induced Acute Kidney Injury]]
::[[Percutaneous coronary intervention contrast-induced acute kidney injury|Contrast-Induced Acute Kidney Injury]]
|-  
|-  
!
!
Line 88: Line 92:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) anaphylactoid reactions|Anaphylactoid Reactions]]
::[[Percutaneous coronary intervention anaphylactoid reactions|Anaphylactoid Reactions]]
|-  
|-  
!
!
Line 94: Line 98:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) statin treatment|Statin Treatment]]
::[[Percutaneous coronary intervention statin treatment|Statin Treatment]]
|-  
|-  
!
!
Line 100: Line 104:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) bleeding risk|Bleeding Risk]]
::[[Percutaneous coronary intervention bleeding risk|Bleeding Risk]]
|-  
|-  
!
!
Line 106: Line 110:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) role of onsite surgical backup|Role of Onsite Surgical Backup]]
::[[Percutaneous coronary intervention role of onsite surgical backup|Role of Onsite Surgical Backup]]
|-  
|-  
!
!


|- bgcolor="PaleTurquoise"
|- bgcolor="CadetBlue"
!
!
Procedural Considerations:
Procedural Considerations:
Line 118: Line 122:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) vascular access|Vascular Access]]
:[[Percutaneous coronary intervention vascular access|Vascular Access]]
|-
|-
!
!
Line 130: Line 134:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) asymptomatic ischemia or CCS class I or II angina|Asymptomatic Ischemia or CCS Class I or II Angina]]
::[[Percutaneous coronary intervention asymptomatic ischemia or CCS class I or II angina|Asymptomatic Ischemia or CCS Class I or II Angina]]
|-
|-
!
!
Line 136: Line 140:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) CCS class III angina|CCS Class III Angina]]
::[[Percutaneous coronary intervention CCS class III angina|CCS Class III Angina]]
|-
|-
!
!
Line 142: Line 146:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) PCI in patients with unstable Angina/non-ST-elevation myocardial infarction|PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction]]
::[[Percutaneous coronary intervention unstable Angina/non-ST-elevation myocardial infarction|Unstable Angina/Non–ST-Elevation Myocardial Infarction]]
|-
|-
!
!
Line 148: Line 152:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::PCI in patients with ST-Elevation Myocardial Infarction:
::ST-Elevation Myocardial Infarction:
|-
|-
!
!
Line 154: Line 158:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:::[[Percutaneous Coronary Intervention (PCI) coronary angiography strategies in STEMI|Coronary Angiography Strategies in STEMI]]
:::[[Percutaneous coronary intervention general and specific considerations|General and Specific Considerations]]
|-
|-
!
!
Line 160: Line 164:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:::[[Percutaneous Coronary Intervention (PCI) primary PCI of the infarct artery|Primary PCI of the Infarct Artery]]
:::[[Percutaneous coronary intervention coronary angiography strategies in STEMI|Coronary Angiography Strategies in STEMI]]
|-
|-
!
!
Line 166: Line 170:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:::[[Percutaneous Coronary Intervention (PCI) delayed or elective PCI in patients with STEMI|Delayed or Elective PCI in patients with STEMI]]
:::[[Percutaneous coronary intervention primary PCI of the infarct artery|Primary PCI of the Infarct Artery]]
|-
|-
!
!
Line 172: Line 176:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:::[[Percutaneous Coronary Intervention (PCI) STEMI: General and Specific Considerations|STEMI: General and Specific Considerations]]
:::[[Percutaneous coronary intervention delayed or elective PCI in patients with STEMI|Delayed or Elective PCI in patients with STEMI]]
|-
|-
!
!
Line 178: Line 182:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:::[[Percutaneous Coronary Intervention (PCI) PCI in fibrinolytic-ineligible patients|PCI in Fibrinolytic-Ineligible Patients]]
:::[[Percutaneous coronary intervention fibrinolytic-ineligible patients|Fibrinolytic-Ineligible Patients]]
|-
|-
!
!
Line 184: Line 188:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:::[[Percutaneous Coronary Intervention (PCI) facilitated PCI|Facilitated PCI]]
:::[[Percutaneous coronary intervention facilitated PCI|Facilitated PCI]]
|-
|-
!
!
Line 190: Line 194:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:::[[Percutaneous Coronary Intervention (PCI) Rescue PCI (PCI After Failed Fibrinolysis)|Rescue PCI]]
:::[[Percutaneous coronary intervention rescue PCI (PCI after failed fibrinolysis)|Rescue PCI]]
|-
|-
!
!
Line 196: Line 200:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:::[[Percutaneous Coronary Intervention (PCI) PCI after successful fibrinolysis or for patients not undergoing primary reperfusion|PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]]
:::[[Percutaneous coronary intervention after successful fibrinolysis or for patients not undergoing primary reperfusion|After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]]
|-
|-
!
!
Line 202: Line 206:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) PCI in patients with cardiogenic shock|PCI in patients with Cardiogenic Shock]]
:[[Percutaneous coronary intervention Cardiogenic shock|Cardiogenic Shock]]
|-
|-
!
!
Line 208: Line 212:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) PCI in patients with prior coronary bypass surgery|PCI in patients with Prior Coronary Bypass Surgery]]
:[[Percutaneous coronary intervention prior coronary bypass surgery|Prior Coronary Bypass Surgery]]
|-
|-
!
!
Line 214: Line 218:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) revascularization before non-cardiac surgery|Revascularization Before Non-cardiac Surgery]]
:[[Percutaneous coronary intervention revascularization before non-cardiac surgery|Revascularization Before Non-cardiac Surgery]]
|-
|-
!
!
Line 220: Line 224:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) coronary stents|Coronary Stents]]
:Adjunctive Diagnostic Devices:
|-
|-
!
!
Line 226: Line 230:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:Adjunctive Diagnostic Devices:
::[[Percutaneous coronary intervention fractional flow reserve|Fractional Flow Reserve]]
|-
|-
!
!
Line 232: Line 236:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) fractional flow reserve|Fractional Flow Reserve]]
::[[Percutaneous coronary intervention intravascular ultrasound|Intravascular Ultrasound]]
|-
|-
!
!
Line 238: Line 242:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) intravascular ultrasound|Intravascular Ultrasound]]
:Adjunctive Therapeutic Devices:
|-
|-
!
!
Line 244: Line 248:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:Adjunctive Therapeutic Devices:
::[[Percutaneous coronary intervention coronary atherectomy|Coronary Atherectomy]]
|-
|-
!
!
Line 250: Line 254:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) coronary atherectomy|Coronary Atherectomy]]
::[[Percutaneous coronary intervention thrombectomy|Thrombectomy]]
|-
|-
!
!
Line 256: Line 260:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) thrombectomy|Thrombectomy]]
::[[Percutaneous coronary intervention laser angioplasty|Laser Angioplasty]]
|-
|-
!
!
Line 262: Line 266:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) laser angioplasty|Laser Angioplasty]]
::[[Percutaneous coronary intervention cutting balloon angioplasty|Cutting Balloon Angioplasty]]
|-
|-
!
!
Line 268: Line 272:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) cutting balloon angioplasty|Cutting Balloon Angioplasty]]
::[[Percutaneous coronary intervention embolic protection devices|Embolic Protection Devices]]
|-
|-
!
!
Line 274: Line 278:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) embolic protection devices|Embolic Protection Devices]]
:[[Percutaneous coronary intervention percutaneous hemodynamic support devices|Percutaneous Hemodynamic Support Devices]]
|-
|-
!
!
Line 280: Line 284:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) percutaneous hemodynamic support devices|Percutaneous Hemodynamic Support Devices]]
:Antiplatelet therapy:
|-
|-
!
!
Line 286: Line 290:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:Antiplatelet therapy:
::[[Percutaneous coronary intervention oral antiplatelet therapy|Oral Antiplatelet Therapy]]
|-
|-
!
!
Line 292: Line 296:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) oral antiplatelet therapy|Oral Antiplatelet Therapy]]
::[[Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists|Glycoprotein IIb/IIIa Receptor Antagonists]]
|-
|-
!
!
Line 304: Line 308:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::::[[Percutaneous Coronary Intervention (PCI) ST-elevation myocardial infarction (STEMI)|STEMI]]
::::[[Percutaneous coronary intervention ST-elevation myocardial infarction (STEMI)|STEMI]]
|-
|-
!
!
Line 310: Line 314:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::::[[Percutaneous Coronary Intervention (PCI) unstable angina / non-ST elevation myocardial infarction (UA/NSTEMI)|UA/NSTEMI]]
::::[[Percutaneous coronary intervention unstable angina / non-ST elevation myocardial infarction (UA/NSTEMI)|UA/NSTEMI]]
|-
|-
!
!
Line 316: Line 320:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::::[[Percutaneous Coronary Intervention (PCI) sudden ischemia heart disease (SIHD)|SIHD]]
::::[[Percutaneous coronary intervention sudden ischemia heart disease (SIHD)|SIHD]]
|-
|-
!
!
Line 322: Line 326:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::Anticoagulant Therapy:
:Anticoagulant Therapy:
|-
|-
!
!
Line 328: Line 332:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) use of parenteral anticoagulants during PCI|Parenteral Anticoagulants During PCI]]
::[[Percutaneous coronary intervention use of parenteral anticoagulants during PCI|Parenteral Anticoagulants During PCI]]
|-
|-
!
!
Line 334: Line 338:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) unfractionated heparin|Unfractionated Heparin]]
::[[Percutaneous coronary intervention unfractionated heparin|Unfractionated Heparin]]
|-
|-
!
!
Line 340: Line 344:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) enoxaparin|Enoxaparin]]
::[[Percutaneous coronary intervention enoxaparin|Enoxaparin]]
|-
|-
!
!
Line 346: Line 350:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) bivalirudin and argatoban|Bivalirudin and Argatroban]]
::[[Percutaneous coronary intervention bivalirudin and argatoban|Bivalirudin and Argatroban]]
|-
|-
!
!
Line 352: Line 356:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) fondaparinux|Fondaparinux]]
::[[Percutaneous coronary intervention fondaparinux|Fondaparinux]]
|-
|-
!
!
Line 358: Line 362:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) no-reflow pharmacological therapies|No-Reflow Pharmacological Therapies]]
::[[Percutaneous coronary intervention no-reflow pharmacological therapies|No-Reflow Pharmacological Therapies]]
|-
|-
!
!
Line 364: Line 368:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::PCI in Specific Anatomic Situations:
:PCI in Specific Anatomic Situations:
|-
|-
!
!
Line 370: Line 374:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) chronic total occlusions|Chronic Total Occlusions]]
::[[Percutaneous coronary intervention chronic total occlusions|Chronic Total Occlusions]]
|-
|-
!
!
Line 376: Line 380:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) saphenous vein grafts|Saphenous Vein Grafts]]
::[[Percutaneous coronary intervention saphenous vein grafts|Saphenous Vein Grafts]]
|-
|-
!
!
Line 382: Line 386:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) bifurcation lesions|Bifurcation Lesions]]
::[[Percutaneous coronary intervention bifurcation lesions|Bifurcation Lesions]]
|-
|-
!
!
Line 388: Line 392:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) aorto-ostial stenoses|Aorto-Ostial Stenoses]]
::[[Percutaneous coronary intervention aorto-ostial stenoses|Aorto-Ostial Stenoses]]
|-
|-
!
!
Line 394: Line 398:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) calcified lesions|Calcified Lesions]]
::[[Percutaneous coronary intervention calcified lesions|Calcified Lesions]]
|-
|-
!
!
Line 400: Line 404:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::PCI in Specific Patient Populations:
:PCI in Specific Patient Populations:
|-
|-
!
!
Line 406: Line 410:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) chronic kidney disease|Chronic Kidney Disease]]
::[[Percutaneous coronary intervention chronic kidney disease|Chronic Kidney Disease]]
|-
|-
!
!
Line 412: Line 416:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) peri-procedural myocardial infarction assessment|Peri-procedural Myocardial Infarction Assessment]]
:[[Percutaneous coronary intervention peri-procedural myocardial infarction assessment|Peri-procedural Myocardial Infarction Assessment]]
|-
|-
!
!
Line 418: Line 422:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) vascular closure devices|Vascular Closure Devices]]
:[[Percutaneous coronary intervention vascular closure devices|Vascular Closure Devices]]
|-
|-
!
!


|- bgcolor="PaleTurquoise"
|- bgcolor="CadetBlue"
!
!
Post-Procedural Considerations:
Post-Procedural Considerations:
Line 430: Line 434:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) post-procedural antiplatelet therapy|Post-procedural Antiplatelet Therapy:]]
:[[Percutaneous coronary intervention post-procedural antiplatelet therapy|Post-procedural Antiplatelet Therapy]]
|-
|-
!
!
Line 436: Line 440:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) proton pump inhibitors and anti-platelet therapy|Proton Pump Inhibitors and Antiplatelet Therapy]]
:[[Percutaneous coronary intervention proton pump inhibitors and anti-platelet therapy|Proton Pump Inhibitors and Antiplatelet Therapy]]
|-
|-
!
!
Line 442: Line 446:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) clopidogrel genetic testing|Clopidogrel Genetic Testing]]
:[[Percutaneous coronary intervention clopidogrel genetic testing|Clopidogrel Genetic Testing]]
|-
|-
!
!
Line 448: Line 452:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) platelet function testing|Platelet Function Testing]]
:[[Percutaneous coronary intervention platelet function testing|Platelet Function Testing]]
|-
|-
!
!
Line 454: Line 458:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) restenosis|Restenosis:]]
:[[Percutaneous coronary intervention restenosis|Restenosis]]
|-
|-
!
!
Line 460: Line 464:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) exercise testing|Exercise Testing]]
:[[Percutaneous coronary intervention exercise testing|Exercise Testing]]
|-
|-
!
!
Line 466: Line 470:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
::[[Percutaneous Coronary Intervention (PCI) cardiac rehabilitation|Cardiac Rehabilitation]]
:[[Percutaneous coronary intervention cardiac rehabilitation|Cardiac Rehabilitation]]
|-
|-
!
!


|- bgcolor="PaleTurquoise"
|- bgcolor="CadetBlue"
!
!
Post-Procedural Considerations:
Quality and Performance Considerations:
|-
|-
!
!
Line 478: Line 482:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) quality and performance|Quality and Performance]]
:[[Percutaneous coronary intervention quality and performance|Quality and Performance]]
|-
|-
!
!
Line 484: Line 488:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) certification and maintenance of certification|Certification and Maintenance of Certification]]
:[[Percutaneous coronary intervention certification and maintenance of certification|Certification and Maintenance of Certification]]
|-
|-
!
!
Line 490: Line 494:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
:[[Percutaneous Coronary Intervention (PCI) certification and maintenance of certification|Certification and Maintenance of Certification]]
:[[Percutaneous coronary intervention operator and institutional competency and volume|Operator and Institutional Competency and Volume]]
|-
|-
!
!

Latest revision as of 13:16, 21 June 2022

Percutaneous Coronary Intervention Guidelines Microchapters

Home

Patient Information

Overview

PCI Approaches:

CAD Revascularization:

Heart Team Approach to Revascularization Decisions
Left Main Coronary Artery Disease
Intervention in left main coronary artery disease
Non-Left Main Coronary Artery Disease
Revascularization to Improve Symptoms
Dual Antiplatelet Therapy Compliance and Stent Thrombosis
Hybrid Coronary Revascularization

Pre-procedural Considerations:

Contrast-Induced Acute Kidney Injury
Anaphylactoid Reactions
Statin Treatment
Bleeding Risk
Role of Onsite Surgical Backup

Procedural Considerations:

Vascular Access
PCI in Specific Clinical Situations:
Asymptomatic Ischemia or CCS Class I or II Angina
CCS Class III Angina
Unstable Angina/Non–ST-Elevation Myocardial Infarction
ST-Elevation Myocardial Infarction:
General and Specific Considerations
Coronary Angiography Strategies in STEMI
Primary PCI of the Infarct Artery
Delayed or Elective PCI in patients with STEMI
Fibrinolytic-Ineligible Patients
Facilitated PCI
Rescue PCI
After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
Cardiogenic Shock
Prior Coronary Bypass Surgery
Revascularization Before Non-cardiac Surgery
Adjunctive Diagnostic Devices:
Fractional Flow Reserve
Intravascular Ultrasound
Adjunctive Therapeutic Devices:
Coronary Atherectomy
Thrombectomy
Laser Angioplasty
Cutting Balloon Angioplasty
Embolic Protection Devices
Percutaneous Hemodynamic Support Devices
Antiplatelet therapy:
Oral Antiplatelet Therapy
Glycoprotein IIb/IIIa Receptor Antagonists
Intravenous Antiplatelet therapy:
STEMI
UA/NSTEMI
SIHD
Anticoagulant Therapy:
Parenteral Anticoagulants During PCI
Unfractionated Heparin
Enoxaparin
Bivalirudin and Argatroban
Fondaparinux
No-Reflow Pharmacological Therapies
PCI in Specific Anatomic Situations:
Chronic Total Occlusions
Saphenous Vein Grafts
Bifurcation Lesions
Aorto-Ostial Stenoses
Calcified Lesions
PCI in Specific Patient Populations:
Chronic Kidney Disease
Peri-procedural Myocardial Infarction Assessment
Vascular Closure Devices

Post-Procedural Considerations:

Post-procedural Antiplatelet Therapy
Proton Pump Inhibitors and Antiplatelet Therapy
Clopidogrel Genetic Testing
Platelet Function Testing
Restenosis
Exercise Testing
Cardiac Rehabilitation

Quality and Performance Considerations:

Quality and Performance
Certification and Maintenance of Certification
Operator and Institutional Competency and Volume

Percutaneous Coronary Intervention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Percutaneous Coronary Intervention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Percutaneous Coronary Intervention

CDC on Percutaneous Coronary Intervention

Percutaneous Coronary Intervention in the news

Blogs on Percutaneous Coronary Intervention

Directions to Hospitals Treating Percutaneous Coronary Intervention

Risk calculators and risk factors for Percutaneous Coronary Intervention

Retrieved from "https://www.wikidoc.org/index.php?title=Template:Percutaneous_Coronary_Intervention&oldid=1726394"